For example, in a β-amyloid-induced rat model of Alzheimer’s disease, sitagliptin improved cognitive status by its antioxidant effects mediated by the activation of NRF2 [28]. Here, NFE2L2 is linked to early-onset autosomal dominant Alzheimer disease.